News Category
Scinai Immunotherapeutics strengthens its CDMO platform with the appointment of Eran Kuratz, a seasoned supply chain and operations expert, to oversee...
Quantum BioPharma announced that patient enrollment in its MS imaging study with Massachusetts General Hospital has reached the midpoint, with prelimi...
Oncotelic Therapeutics, Inc. was featured in a NetworkNewsAudio editorial discussing innovations in central nervous system drug delivery, specifically...
Oncotelic Therapeutics was featured in a BioMedWire editorial emphasizing its intranasal nose-to-brain delivery platform as a critical innovation to b...
Oncotelic Therapeutics emphasizes its partnership-driven approach to advance oncology and rare disease drug candidates, citing a $249 million valuatio...
Sartorius AG's Supervisory Board extends Dr. René Faber's appointment for five years until 2031, ensuring leadership continuity in its Bioprocess Solu...
Scinai Immunotherapeutics received a Nasdaq notice for failing to maintain the minimum bid price, but has a 180-day period to regain compliance.
SGX945 (dusquetide) from Soligenix has received PIM designation from the UK MHRA for Behcet's Disease, potentially accelerating patient access to a pr...
Silo Pharma's board has approved a $1 million share repurchase program, signaling confidence in the company's value and providing potential support fo...
